8.70
Schlusskurs vom Vortag:
$8.56
Offen:
$8.58
24-Stunden-Volumen:
123.78K
Relative Volume:
0.79
Marktkapitalisierung:
$106.46M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-38.70M
KGV:
-1.863
EPS:
-4.67
Netto-Cashflow:
$-36.86M
1W Leistung:
+7.94%
1M Leistung:
+5.58%
6M Leistung:
-23.35%
1J Leistung:
-85.07%
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Firmenname
Corbus Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
617-963-0103
Adresse
500 RIVER RIDGE DRIVE, NORWOOD, MA
Vergleichen Sie CRBP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CRBP
Corbus Pharmaceuticals Holdings Inc
|
8.70 | 98.63M | 1.54M | -38.70M | -36.86M | -4.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-28 | Eingeleitet | William Blair | Outperform |
2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
2024-07-30 | Eingeleitet | Wedbush | Outperform |
2024-07-22 | Fortgesetzt | H.C. Wainwright | Buy |
2024-06-26 | Eingeleitet | B. Riley Securities | Buy |
2024-06-03 | Bestätigt | Oppenheimer | Outperform |
2024-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
2024-03-06 | Hochstufung | Jefferies | Hold → Buy |
2020-09-08 | Herabstufung | BTIG Research | Buy → Neutral |
2020-09-08 | Herabstufung | Jefferies | Buy → Hold |
2020-09-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2020-09-08 | Herabstufung | ROTH Capital | Buy → Neutral |
2020-07-07 | Eingeleitet | ROTH Capital | Buy |
2020-06-17 | Eingeleitet | BTIG Research | Buy |
2020-03-26 | Eingeleitet | Nomura | Buy |
2019-04-05 | Eingeleitet | Jefferies | Buy |
2019-03-20 | Eingeleitet | Oppenheimer | Outperform |
2019-01-11 | Bestätigt | Cantor Fitzgerald | Overweight |
2018-12-26 | Eingeleitet | H.C. Wainwright | Buy |
2018-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
2018-10-24 | Eingeleitet | B. Riley FBR | Buy |
2018-01-19 | Eingeleitet | Raymond James | Outperform |
2017-12-14 | Bestätigt | Cantor Fitzgerald | Overweight |
2017-11-08 | Bestätigt | Noble Financial | Buy |
2017-09-29 | Fortgesetzt | Noble Financial | Buy |
2017-03-30 | Bestätigt | Cantor Fitzgerald | Overweight |
2016-11-15 | Bestätigt | JMP Securities | Mkt Outperform |
2016-11-11 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten
What drives Corbus Pharmaceuticals Holdings Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com
Why Corbus Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionElite Stock Shortlist - Newser
Corbus Pharmaceuticals Holdings Inc. Stock Analysis and ForecastMarket-leading profit generation - jammulinksnews.com
What analysts say about Corbus Pharmaceuticals Holdings Inc. stockOutstanding yields - jammulinksnews.com
Is Corbus Pharmaceuticals Holdings Inc. a good long term investmentOutstanding risk-reward balance - PrintWeekIndia
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance
(CRBP) Proactive Strategies - news.stocktradersdaily.com
why corbus pharmaceuticals holdings inc. stock attracts strong analyst attentionCapital Safe Stock Watchlist - Newser
What makes Corbus Pharmaceuticals Holdings Inc. stock price move sharplyPotential Rocket List - Newser
How Corbus Pharmaceuticals Holdings Inc. stock performs during market volatilityLow Risk ROI Maximization - Newser
(CRBP) Long Term Investment Analysis - news.stocktradersdaily.com
Bullish Sentiment Across The Cannabis SpaceCheck Full Movers For July 9, 2025 - Benzinga
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Corbus begins multiple ascending dose portion of CRB-913 obesity trial - Investing.com
Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM:CRBP) dropped from Russell Small Cap Completeness Index - MarketScreener
How the (CRBP) price action is used to our Advantage - news.stocktradersdaily.com
Cannabis Stock Movers For June 27, 2025 - Benzinga
Corbus Cancer Drug Shows Promise: New Phase 1 Trial Combines Novel Nectin-4 ADC With Keytruda - Stock Titan
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium - GlobeNewswire
Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - Seeking Alpha
Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $50.88 - Defense World
Bank of America Corp DE Buys 7,207 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
11,027 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Bought by Two Sigma Advisers LP - Defense World
(CRBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Nuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com
Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Deutsche Bank AG - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLC - Defense World
Northern Trust Corp Acquires 11,400 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
BNP Paribas Financial Markets Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewswire
Corbus Pharmaceuticals CEO Set to Reveal Latest Corporate Strategy at Major Jefferies Healthcare Conference - Stock Titan
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $50.88 Average Target Price from Analysts - Defense World
Mizuho Securities Adjusts Corbus Pharmaceuticals Price Target to $32 From $42, Maintains Outperform Rating - marketscreener.com
Mizuho Cuts Price Target on Corbus Pharmaceuticals Holdings to $32 From $42, Keeps Outperform Rating - marketscreener.com
Cannabis Stock Movers For May 20, 2025 - Benzinga
Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):